Cargando…
SAT-366 Hypercalcemia Due to Castleman’s Disease
Castleman’s disease is a group of poorly understood lymphoproliferative disorders in which pro-inflammatory cytokines are hyper-produced, causing a constellation of symptoms. This patient was diagnosed with a rare subtype of idiopathic multicentric Castleman’s called TAFRO, which is a subclass chara...
Autores principales: | Khan, Sarah Adil, Shah, Neel L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208423/ http://dx.doi.org/10.1210/jendso/bvaa046.195 |
Ejemplares similares
-
SAT-499 Denosumab for Treatment of Hypercalcemia in Myelofibrosis
por: Wong, Beatrice, et al.
Publicado: (2019) -
SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-359 Hypercalcemia - Is This Sarcoidosis, Hyperparathyroidism, or Both?
por: Veeramachaneni, Ravali, et al.
Publicado: (2020) -
SAT-503 A Rare Case of Hypercalcemia Due to PTH Secreting Lung Adenocarcinoma
por: Gonzalez-Falero, Andrea, et al.
Publicado: (2019) -
SAT-497 Importance of OTC Medications in Hypercalcemia
por: Yedla, Niharika, et al.
Publicado: (2019)